The DOI matches its Crossref record; 220 of the 220 references it cites were found in a registry or an index.
Cytosolic phospholipase A2: physiological function and role in disease
Open accessAbstract
The group IV phospholipase A2 (PLA2) family is comprised of six intracellular enzymes (GIVA, -B, -C, -D, -E, and -F) commonly referred to as cytosolic PLA2 (cPLA2)α, -β, -γ, -δ, -ε, and -ζ. They contain a Ser-Asp catalytic dyad and all except cPLA2γ have a C2 domain, but differences in their catalytic activities and subcellular localization suggest unique regulation and function. With the exception of cPLA2α, the focus of this review, little is known about the in vivo function of group IV enzymes. cPLA2α catalyzes the hydrolysis of phospholipids to arachidonic acid and lysophospholipids that are precursors of numerous bioactive lipids. The regulation of cPLA2α is complex, involving transcriptional and posttranslational processes, particularly increases in calcium and phosphorylation. cPLA2α is a highly conserved widely expressed enzyme that promotes lipid mediator production in human and rodent cells from a variety of tissues. The diverse bioactive lipids produced as a result of cPLA2α activation regulate normal physiological processes and disease pathogenesis in many organ systems, as shown using cPLA2α KO mice. However, humans recently identified with cPLA2α deficiency exhibit more pronounced effects on health than observed in mice lacking cPLA2α, indicating that much remains to be learned about this interesting enzyme.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–220 of 220
Ueno, N., Taketomi, Y., Yamamoto, K., Hirabayashi, T., Kamei, D., Kita, Y., Shimizu, T., Shinzawa, K., Tsujimoto, Y., Ikeda, K., et al. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.290312 · Cited by 31
The role of phospholipase A2-derived mediators in obesity
Abbott, M. J., Tang, T., & Sul, H. S. (2010) · Drug Discovery Today Disease Mechanisms · doi:10.1016/j.ddmec.2011.01.003 · Cited by 27
Protective role for cytosolic phospholipase A2α in autoimmune diabetes of mice
Oikawa, Y., Yamato, E., Tashiro, F., Yamamoto, M., Uozumi, N., Shimada, A., Shimizu, T., & Miyazaki, J. (2005) · FEBS Letters · doi:10.1016/j.febslet.2005.06.024 · Cited by 27
Guo, C., Li, J., Myatt, L., Zhu, X.-O., & Sun, K. (2010) · Molecular Endocrinology · doi:10.1210/me.2009-0488 · Cited by 22
Kurusu, S., Sapirstein, A., & Bonventre, J. V. (2012) · The FASEB Journal · doi:10.1096/fj.12-203968 · Cited by 21
Uozumi, N., Kita, Y., & Shimizu, T. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.5.3558 · Cited by 20
Last, V., Williams, A., & Werling, D. (2012) · BMC Neuroscience · doi:10.1186/1471-2202-13-106 · Cited by 19
Whalen, K., Legault, H. M., Hang, C., Hill, A., Kasaian, M. T., Donaldson, D. D., Bensch, G. W., Bensch, G. W., Baker, J., Reddy, P. S., et al. (2008) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.2008.03059.x · Cited by 18
Kinehara, M., Fukuda, I., Yoshida, K., & Ashida, H. (2008) · Genes & Genetic Systems · doi:10.1266/ggs.83.455 · Cited by 18
Su, L., Wang, D., Yang, D. U., Shen, Y., & Ying-hong, H. (2013) · The Cerebellum · doi:10.1007/s12311-012-0444-9 · Cited by 17
Brown, N., Morrow, J. D., Slaughter, J. C., Paria, B. C., & Reese, J. (2009) · Biology of Reproduction · doi:10.1095/biolreprod.109.079061 · Cited by 17
Kinehara, M., Fukuda, I., Yoshida, K., & Ashida, H. (2009) · Journal of Bioscience and Bioengineering · doi:10.1016/j.jbiosc.2009.04.015 · Cited by 15
cPLA2α knockout mice exhibit abnormalities in the architecture and synapses of cortical neurons
Qu, B., Gong, Y., Sinclair, D. A., Fu, M., Perl, D. P., & Diaz-Arrastia, R. R. (2012) · Brain Research · doi:10.1016/j.brainres.2012.12.018 · Cited by 14
Guo, C., Yang, Z. H., Li, W., Zhu, P., Myatt, L., & Sun, K. (2007) · Biology of Reproduction · doi:10.1095/biolreprod.107.063990 · Cited by 13
Yang, D., Ji, H., Zhang, X., Yue, H., Lin, L., Ma, Y., Huang, X.-N., Fu, J. X., & Wang, W.-Z. (2014) · Mediators of Inflammation · doi:10.1155/2014/890139 · Cited by 12
Tanaka, K., Yamamoto, Y., Oginö, K., Tsujimoto, S., Saito, M., Uozumi, N., Shimizu, T., & Hisatome, I. (2011) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.110.218370 · Cited by 12
Hypoxia-sensitive domain in the human cytosolic phospholipase A2 promoter
Alexandrov, P. N., Cui, J.-G., & Lukiw, W. J. (2006) · Neuroreport · doi:10.1097/01.wnr.0000201506.61373.99 · Cited by 9
A distal enhancer controls cytokine-dependent human cPLA2α gene expression
Bickford, J. S., Beachy, D. E., Newsom, K. J., Barilovits, S. J., Herlihy, J.-D. H., Qiu, X., Walters, J. N., Li, N., & Nick, H. S. (2013) · Journal of Lipid Research · doi:10.1194/jlr.m037382 · Cited by 7
Antisense inhibition of phospholipase A2
Touqui, L. (2012) · Critical Care Medicine · doi:10.1097/ccm.0b013e31825151bd · Cited by 2
Neidhart (2000) · Pure Amsterdam UMC · doi:10.1002/1529-0131(200012)43:12 · Cited by 1
Cited by
Bioactive lipids, inflammation and chronic diseases
Leuti, A., Fazio, D., Fava, M., Piccoli, A., Oddi, S., & Maccarrone, M. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.06.028 · Cited by 358
Calder, P. C. (2020) · Essays in Biochemistry · doi:10.1042/ebc20190083 · Cited by 321
Glaser, E. P., Kopper, T. J., Bailey, W. M., Kashif, H. K., Kumari, R., Stewart, A. N., & Gensel, J. C. (2025) · Scientific Reports · doi:10.1038/s41598-024-84936-6 · Cited by 315
Changes in lipids composition and metabolism in colorectal cancer: a review
Pakiet, A., Kobiela, J., Stepnowski, P., Sledzinski, T., & Mika, A. (2019) · Lipids in Health and Disease · doi:10.1186/s12944-019-0977-8 · Cited by 314
Docosahexaenoic acid (DHA): An essential nutrient and a nutraceutical for brain health and diseases
Sun, G. Y., Simonyi, A., Fritsche, K. L., Chuang, D. Y., Hannink, M., Gu, Z., Greenlief, C. M., Yao, J. K., Lee, J. C., & Beversdorf, D. Q. (2018) · Prostaglandins, Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2017.03.006 · Cited by 309
Metadata
- Authors
- Leslie, C. C.
- Venue
- Journal of Lipid Research
- Publisher
- Elsevier BV
- Published
- 2015-08
- Volume
- 56
- Issue
- 8
- Pages
- 1386-1402
- ISSN
- 0022-2275 (ISSN-L)
- OpenAlex
- W2093533236
- Cited by
- 413
- References
- 220
- FWCI
- 12.49
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.